ISSN:

Journal Home

Advances in Rheumatology Q3 Unclaimed

BioMed Central Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Advances in Rheumatology is a journal indexed in SJR in Rheumatology with an H index of 43. It is an CC BY Journal with a Double blind peer review review system The scope of the journal is focused on rheumatology, rheumatic diseases. It has an SJR impact factor of 0,645 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,645.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Rheumatology (Q3)

Price

0 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,645

SJR Impact factor

43

H Index

91

Total Docs (Last Year)

174

Total Docs (3 years)

3934

Total Refs

380

Total Cites (3 years)

170

Citable Docs (3 years)

1.9

Cites/Doc (2 years)

43.23

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Scleroderma and Related Disorders Q3
International Journal of Rheumatic Diseases Q3
International Journal of Rheumatology Q3
Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders Q3
Reumatologia Q3

Compare this journals

Aims and Scope

Rheumatology Rheumatic diseases